Hyperadrenergic postural tachycardia syndrome associated with augmented neurovascular transduction
DBP<sub>VM2l_rise</sub> ≥ 15 mmHg could be a sympathetic clinical marker and could identify hyperadrenergic POTS, characterized by enhanced neurovascular transduction despite comparable MSNA levels. This novel pathophysiological insight underscores the importance of sympathetic markers in POTS clinical management.
Authors
- Raffaello Furlan (ORCID: https://orcid.org/0000-0001-5209-6786)
- T. E. Cayton (ORCID: https://orcid.org/0000-0003-1770-3661)
- Luis E. Okamoto (ORCID: https://orcid.org/0000-0001-6914-7287)
- A. Diedrich
- Ruijing Han
- Surat Kulapatana (ORCID: https://orcid.org/0000-0002-2564-2611)
- Giris Jacob
- William D. Dupont
- Vasile Urechie
- Stefano Rigo
Institutions
- Siriraj Hospital (TH)
- Humanitas University (IT)
- Vanderbilt University (US)
- Tel Aviv Sourasky Medical Center (IL)
- IRCCS Humanitas Research Hospital (IT)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Clinical Autonomic Research
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1007/s10286-025-01183-z
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00